KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biomarin Pharmaceutical (BMRN) Asset Utilization Ratio: 2009-2025

Historic Asset Utilization Ratio for Biomarin Pharmaceutical (BMRN) over the last 14 years, with Sep 2025 value amounting to 0.41.

  • Biomarin Pharmaceutical's Asset Utilization Ratio rose 3.80% to 0.41 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.41, marking a year-over-year increase of 3.80%. This contributed to the annual value of 0.41 for FY2024, which is 12.73% up from last year.
  • Per Biomarin Pharmaceutical's latest filing, its Asset Utilization Ratio stood at 0.41 for Q3 2025, which was down 2.14% from 0.42 recorded in Q2 2025.
  • Biomarin Pharmaceutical's Asset Utilization Ratio's 5-year high stood at 0.42 during Q2 2025, with a 5-year trough of 0.31 in Q4 2021.
  • For the 3-year period, Biomarin Pharmaceutical's Asset Utilization Ratio averaged around 0.38, with its median value being 0.37 (2024).
  • As far as peak fluctuations go, Biomarin Pharmaceutical's Asset Utilization Ratio decreased by 17.48% in 2021, and later grew by 15.92% in 2024.
  • Biomarin Pharmaceutical's Asset Utilization Ratio (Quarterly) stood at 0.31 in 2021, then rose by 7.63% to 0.33 in 2022, then grew by 7.27% to 0.36 in 2023, then rose by 15.92% to 0.41 in 2024, then rose by 3.80% to 0.41 in 2025.
  • Its last three reported values are 0.41 in Q3 2025, 0.42 for Q2 2025, and 0.42 during Q1 2025.